Heart researchers from Cambridge University have received £3 million from the British Heart Foundation (BHF) to fund a BHF Centre of Research Excellence for the next five years. Cambridge is just one of six centres in the UK to be awarded Centre of Excellence funding. The Cambridge BHF Centre of Research Excellence will be a […]
MRC Award for Primary Biliary Cirrhosis Research
A £6 million programme, funded by Industry and the MRC, to carry out the largest ever study to develop new treatments and improve existing therapy for patients with a life threatening liver disease, Primary Biliary Cirrhosis (PBC) has been awarded to four centres in the UK – Cambridge, Newcastle, Imperial College and Birmingham. £5 million […]
$11m raised to develop new anticoagulant drug
A new spin-out company from the University of Cambridge and Addenbrooke’s Hospital, XO1 Ltd, has raised $11m to develop an anticoagulant drug with the potential to save millions of lives by preventing heart attacks without causing bleeding, the side effect of all antithrombotic agents such as warfarin. The drug Ichorcumab is a synthetic antibody based […]
New drug could protect from tissue damage following heart attack
Clinical Trials UnitScientists led by the University of Cambridge and the Medical Research Council (MRC) have developed a new drug that could help reduce the tissue damage that occurs following a heart attack, stroke or major surgery. Tests in mice have shown that the compound, called MitoSNO, protects heart tissue from reperfusion injury, which occurs […]
- « Previous Page
- 1
- …
- 40
- 41
- 42
